* To delay European application until 2012 * Will conduct additional two-year study TOKYO, June 4 - Takeda Pharmaceutical Co said it would not seek European approval for a key drug candidate that it has...
* Halted trial fails to meet goal * Progression-free survival improves for subgroup * Mature survival data expected end 2009 or early 2010 ORLANDO, Fla., May 30 - Synta Pharmaceuticals Corp <SNTA.O>, which in February...
TOKYO, May 29 - Takeda Pharmaceutical Co, Japan's largest drugmaker, said it would not bid for the pharmaceutical unit of Belgian chemicals, plastics and drugs company Solvay SA. Solvay is set to receive a range...
BRUSSELS, May 14 - Israel's Teva Pharmaceutical Industries and Swiss drugs industry supplier Lonza Group won approval from the European Commission on Thursday for a joint venture in the biosimilar industry. The European Commission, executive...
BRUSSELS, May 14 - Israel's Teva Pharmaceutical Industries and Swiss drugs industry supplier Lonza Group won approval from the European Commission on Thursday for a joint venture in the biosimilar industry. The European Commission, executive...
SHANGHAI, May 13 - BioPharm Asia Inc, a China-focused pharmaceutical maker and drug retailer, aims to boost its retail outlets to more than 5,000 by 2011 and will raise $400 million to fund the expansion,...
TOKYO, May 11 - Takeda Pharmaceutical Co, Japan's biggest drugmaker, reported on Monday a 39 percent drop in annual recurring profit to an eight-year low due to costly acquisitions and forecast a 22 percent rise...
May 7 - Given the heightened awareness of influenza and the threat of a global pandemic, it is not surprising that the pharmaceutical industry is dedicating significant research efforts to the development of new therapeutics....
* Q1 non-GAAP earnings per share $0.71, beating forecasts * Company seeks more acquisitions following Barr * Maintains 2009, 2010 outlook TEL AVIV, May 5 - Teva Pharmaceutical Industries, the world's biggest generic drugs maker,...
Avantium Technologies' Crystalline has been designed to address the need in the pharmaceutical industry to learn as much as possible about a drug candidate early in...